title: An additional line of therapy with pegylated interferon and ribavirin after rituximab in a patient with hepatitis C virus-related mixed cryoglobulinaemia and indolent non-Hodgkin's lymphoma previously treated with interferon.
authors.affiliation: Section of Haematology and BMT Unit, Cremona Hospital, Cremona, Italy. endri76@libero.it
authors.forename: Endri
authors.initials: E
authors.lastname: Mauro
authors.forename: Mariangela
authors.initials: M
authors.lastname: Pedata
authors.forename: Anna
authors.initials: A
authors.lastname: Ermacora
authors.forename: Cesare
authors.initials: C
authors.lastname: Mazzaro
mesh_terms: D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D000998:Antiviral Agents / Q000008:administration & dosage*; D003449:Cryoglobulinemia / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000008:administration & dosage*; D008228:Lymphoma, Non-Hodgkin / Q000150:complications / Q000188:drug therapy*; D012074:Remission Induction; D012254:Ribavirin / Q000008:administration & dosage*; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000998:Antiviral Agents; D012254:Ribavirin; D000069283:Rituximab; D007372:Interferons